Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals.
Philip G JosephJeffrey S HealeyParminder RainaStuart J ConnollyQuazi IbrahimRajeev GuptaAlvaro AvezumAntonio L DansPatricio López-JaramilloKaren YeatesKoon TeoReuben DoumaAhmad BahonarJephat ChifambaFernando LanasGilles R DagenaisScott A LearRajesh KumarAndre P KengneMiraç Vural KeskinlerViswanathan MohanPrem MonyKhalid F AlhabibHugo W HuismanThomas IypeKatarzyna ZatonskaRosnah IsmailKhawar KazmiAnnika RosengrenOmar RahmanAfzalhussein M YusufaliLi WeiAndres OrlandiniShofiqul IslamSumathy RangarajanSalim Yusufnull nullPublished in: Cardiovascular research (2022)
Large variations in AF prevalence occur in different regions and countries grouped by income level, but this is only partially explained by traditional AF risk factors. Antithrombotic therapy is infrequently used in poorer countries despite the high risk of stroke associated with AF.
Keyphrases
- atrial fibrillation
- risk factors
- oral anticoagulants
- middle aged
- catheter ablation
- left atrial
- left atrial appendage
- direct oral anticoagulants
- heart failure
- percutaneous coronary intervention
- mental health
- quality improvement
- physical activity
- stem cells
- combination therapy
- mesenchymal stem cells
- brain injury
- acute coronary syndrome